GUIDELINES

GENERAL GUIDELINES

  1. We do not accept any work that has been published.

  2. All abstracts have to be submitted in ENGLISH.

  3. Abstracts will be evaluated based on their scientific content and novelty, and meritorious abstracts will be selected for oral presentation. All other shortlisted abstracts will be scheduled for poster presentation.

  4. Any abstract containing statements, symbols or other contact that are subjective and unscientific in nature will be rejected.

 

Abstract Submission Topics
  • Clinical Ethics

  • Pain and Symptom Management

  • Palliative Care in Non-cancer

  • Ageing and Geriatrics

  • Paediatric Palliative Care

  • Bereavement, Grief and Loss

  • Spirituality and Psychological health

  • Arts and Humanities (including art and music therapy)

  • Policy or Programme Advocacy, Development and Evaluation

  • Professional Issues and the Professional Worker

  • Education, Training and Supervision

  • Advance Care Planning and Communication

  • Rehabilitation and Clinical Nutrition

  • Family Care-givers

  • Self-Care and Wellness

  • Complementary Therapies /Natural Analgesics

Please choose the most appropriate topic when submitting the abstract.

 

Registration and Expenses

All presenting authors must be registered for APHC. Authors who have not paid their registration fees will not be allowed to enter. All  expenses associated with the submission and presentation of the abstract are the sole responsibility of the presenter.

ABSTRACT CONTENT PREPARATION

Language

Abstracts must be written and presented in English. Careful typing and proofreading is essential. The accepted abstract will be published as submitted. Once the abstract is submitted, changes, corrections or rewording will not be possible.

The Scientific Committee reserves the right to reject abstracts which are presented in poor English or to request an immediate revision.

 

Word Count

The maximum content of the abstract is limited to 3,000 characters (including title, body, spaces, tables and graphics). Each picture counts as 500 characters.

 

Topic Selection

Please choose the most appropriate topic from the drop down menu.

 

Title

The title should clearly define the topic of your research. Do not identify your institution in the title. There is no maximum length for the title. However, the characters in the title are included in your total character count. The first letter of any sentence in the title will automatically begin with a capital letter. Do not type the entire title in capital letters.

 

Author(s)

Type the full name of all authors. Omit any titles, degrees and institutional affiliations. It is advisable to check the correct spelling of the family name and initials of each author. If authors are from the same institution, the name of the institution must be written in the exact same way.

 

Affiliation

Type the institution, Department, City and Country. if co-authors are from the same institution, the software will automatically copy all information into the subsequent boxes. You do not have to type the information again. if co-authors are not from the same institution, you can edit the boxes.

 

Abstract Content

The following headings have been formatted for you and should NOT be entered in the text fields:
• Introduction & objectives
• Materials & methods
• Results
• Conclusion
State the objective of the study, describe the material and methods and summarise the results of the research. You need to present sufficient details to support the conclusions reached.

Please use standard abbreviations and generic drug names. Abbreviations should be spelled out, in parentheses, in the first use in the abstract. You can use the special keys to insert tables, pictures or specific characters.

 

Data Protection Policy

All patient information should be de-identified. Patient’s faces should be blurred when used in images.  Seek necessary permission from the copyright owner if copyrighted figures, images, or content are used in the abstract..

 

Acknowledgements

Do not include references, credits or grant support  in your abstract.

 

Human Experimentation

Any human experimentation conducted as part of the submitted abstract(s) must follow the protocol approved by the institutional or local committee on ethics in human investigation; or, if no such committee exists, the investigation should have been conducted in accordance with the principles of the World Medical Association’s Helsinki Declaration.

 

Data Presentation

Abstracts that describe investigations of compounds that involve inadequate numbers of study subjects, or abstracts that lack quantitative data may not be accepted. Authors should not “split” data to create several abstracts.
Abstracts containing same data submitted from the same institution (and/or individuals) describing the same study population may be disqualified. Abstracts without data will not be considered.

 

Submission Deadline

Deadline for abstract submission is February 1st, 2019.
To avoid incidences where your abstract cannot be submitted due to technical difficulties, computer problems or other reasons, you are advised to submit your abstract early.

 

Important Dates to Note

  • 1 February 2019 – Abstract submission close

  • February to March – Notification of abstract acceptance (Please register first in order to enjoy the early bird rate. You may make payment upon receiving the notification email that your abstract is accepted)

  • 10 July 2019 – Payment deadline